Results 1 to 10 of about 1,618 (156)

Variant Predictions in Congenital Adrenal Hyperplasia Caused by Mutations in CYP21A2 [PDF]

open access: yesFrontiers in Pharmacology, 2022
CYP21A2 deficiency represents 95% of congenital adrenal hyperplasia (CAH) cases, a group of genetic disorders that affect steroid biosynthesis. The genetic and functional analysis provide critical tools to elucidate complex CAH cases.
Arnaldo Zaha   +2 more
exaly   +7 more sources

Characterization of Mutations Causing CYP21A2 Deficiency in Brazilian and Portuguese Populations [PDF]

open access: yesInternational Journal of Molecular Sciences, 2021
Deficiency of 21-hydroxylase enzyme (CYP21A2) represents 90% of cases in congenital adrenal hyperplasia (CAH), an autosomal recessive disease caused by defects in cortisol biosynthesis.
Zaha, Arnaldo   +26 more
core   +5 more sources

Data on the 21-Hydroxylase deficient CAH patients and the identification of known/novel mutations in CYP21A2 gene

open access: yesData in Brief, 2017
This article presents the dataset regarding spectrum of mutations in 21-Hydroxylase deficient CAH patients as described in “The spectrum of CYP21A2 mutations in Congenital Adrenal Hyperplasia in an Indian cohort” (R. Khajuria, R. Walia, A.
Ragini Khajuria   +3 more
doaj   +2 more sources

Congenital adrenal hyperplasia due to two rare CYP21A2 variant alleles, including a novel attenuated CYP21A1P/CYP21A2 chimera

open access: yesMolecular Genetics & Genomic Medicine, 2023
Background Congenital adrenal hyperplasia (CAH) due to 21‐hydroxylase (21OH) deficiency is an autosomal recessive inborn error of cortisol biosynthesis, with varying degrees of aldosterone production.
Qizong Lao   +4 more
doaj   +3 more sources

A new CYP21A1P/CYP21A2 chimeric gene identified in an Italian woman suffering from classical congenital adrenal hyperplasia form [PDF]

open access: yesBMC Medical Genetics, 2009
Background More than 90% of Congenital Adrenal Hyperplasia (CAH) cases are associated with mutations in the 21-hydroxylase gene (CYP21A2) in the HLA class III area on the short arm of chromosome 6p21.3.
Toscano Vincenzo   +6 more
doaj   +3 more sources

CYP21A2 intronic variants causing 21-hydroxylase deficiency

open access: yesMetabolism, 2017
Congenital adrenal hyperplasia (CAH) is an autosomal recessive disorder mainly caused by defects in the steroid 21-hydroxylase gene (CYP21A2). Most of CYP21A2 mutations result from intergenic recombinations between CYP21A2 and closely linked CYP21A1P ...
Cecilia Zuppi   +16 more
core   +4 more sources

In Silico Structural and Biochemical Functional Analysis of a Novel CYP21A2 Pathogenic Variant. [PDF]

open access: yesInternational Journal of Molecular Sciences, 2020
Classical congenital adrenal hyperplasia (CAH) caused by pathogenic variants in the steroid 21-hydroxylase gene (CYP21A2) is a severe life-threatening condition.
Monica Dines   +23 more
core   +6 more sources

CYP21A2 mutations in women with polycystic ovary syndrome (PCOS)

open access: yesHormone and Metabolic Research, 2013
The question of the contribution of CYP21A2 heterozygosity to the development of polycystic ovary syndrome (PCOS) has repeatedly been raised in the literature. The available data, however, do not offer a satisfactory answer.
Dacou-Voutetakis, C.   +6 more
core   +5 more sources

Variations in the 3′UTR of the CYP21A2 Gene in Heterozygous Females with Hyperandrogenaemia [PDF]

open access: yesInternational Journal of Endocrinology, 2017
Heterozygosity for CYP21A2 mutations in females is possibly related to increased risk of developing clinical hyperandrogenism. The present study was designed to seek evidence on the phenotype-genotype correlation in female children, adolescents, and ...
Vassos Neocleous   +10 more
doaj   +3 more sources

A Capillary Electrophoresis-Based Assay for Carrier Screening of the Hotspot Mutations in the CYP21A2 Gene

open access: yesHeliyon
Molecular genetic analysis of the cytochrome P450 family 21 subfamily A member 2 (CYP21A2) gene is challenging owing to the highly homologous with its pseudogene. A reliable approach for the large-scale population screening of CYP21A2 is required.
Binbin Shao, Qing Cheng
exaly   +3 more sources

Home - About - Disclaimer - Privacy